Overview

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

Status:
Completed
Trial end date:
2007-10-03
Target enrollment:
Participant gender:
Summary
Study objective is to verify the superiority of CTZ DS to the placebo groups in the change of total nasal symptom score (TNSS) over the total treatment period from the score of the baseline assessment period.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Cetirizine